Tempus AI Other Non-Current Liabilities 2023-2024 | TEM

Tempus AI other non-current liabilities from 2023 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Tempus AI other non-current liabilities for the quarter ending September 30, 2024 were $0.159B, a INF% increase year-over-year.
  • Tempus AI other non-current liabilities for 2023 were $0.11B, a 11.58% increase from 2022.
  • Tempus AI other non-current liabilities for 2022 were $0.098B, a INF% increase from .
  • Tempus AI other non-current liabilities for were $0B, a NAN% decline from .
Tempus AI Annual Other Non-Current Liabilities
(Millions of US $)
2023 $110
2022 $98
Tempus AI Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $159
2024-06-30 $113
2024-03-31 $112
2023-12-31 $110
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $1,124
Sector Industry Market Cap Revenue
Medical Medical Information Systems $13.495B $0.321B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.209B 54.83
Hims & Hers Health (HIMS) United States $15.018B 381.89
Inspire Medical Systems (INSP) United States $5.303B 103.31
IRhythm Technologies (IRTC) United States $3.538B 0.00
Privia Health (PRVA) United States $3.060B 255.00
Enovis (ENOV) United States $2.533B 16.87
Clover Health Investments (CLOV) United States $2.280B 0.00
Azenta (AZTA) United States $2.075B 96.64
Schrodinger (SDGR) United States $1.895B 0.00
Omnicell (OMCL) United States $1.858B 40.53
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.465B 0.00
Butterfly Network (BFLY) United States $1.004B 0.00
Talkspace (TALK) United States $0.652B 0.00
Fulgent Genetics (FLGT) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.517B 0.00
TruBridge (TBRG) United States $0.426B 124.04
Nyxoah SA (NYXH) Belgium $0.357B 0.00
Health Catalyst (HCAT) United States $0.338B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.319B 0.00
Pulmonx (LUNG) United States $0.262B 0.00
American Well (AMWL) United States $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
111 (YI) China $0.069B 0.00
CareCloud (CCLD) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Outset Medical (OM) United States $0.050B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.028B 0.00
MSP Recovery (MSPR) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.005B 0.00
Syra Health (SYRA) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00